Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cg Oncology Inc (CGON)

Cg Oncology Inc (CGON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,947,549
  • Shares Outstanding, K 76,225
  • Annual Sales, $ 1,140 K
  • Annual Income, $ -88,040 K
  • EBIT $ -134 M
  • EBITDA $ -139 M
  • 60-Month Beta 0.86
  • Price/Sales 1,758.73
  • Price/Cash Flow N/A
  • Price/Book 2.84

Options Overview Details

View History
  • Implied Volatility 69.83% ( +9.43%)
  • Historical Volatility 47.90%
  • IV Percentile 30%
  • IV Rank 20.47%
  • IV High 147.24% on 04/22/25
  • IV Low 49.90% on 12/24/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 6,164
  • Volume Avg (30-Day) 652
  • Put/Call OI Ratio 0.24
  • Today's Open Interest 13,567
  • Open Int (30-Day) 11,580

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.49
  • Number of Estimates 5
  • High Estimate -0.45
  • Low Estimate -0.56
  • Prior Year -0.28
  • Growth Rate Est. (year over year) -75.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.79 +3.07%
on 05/27/25
28.06 -8.95%
on 05/21/25
-1.01 (-3.80%)
since 05/20/25
3-Month
14.80 +72.64%
on 04/09/25
32.30 -20.90%
on 04/28/25
-2.20 (-7.93%)
since 03/20/25
52-Week
14.80 +72.64%
on 04/09/25
40.47 -36.87%
on 11/11/24
-6.56 (-20.43%)
since 06/20/24

Most Recent Stories

More News
Cancer Rates Are Surging in Young Adults — Here’s Where the Smart Money Is Going

Issued on behalf of Oncolytics Biotech Inc.   Vancouver, BC – June 18, 2025 – USA News Group News Commentary – According to a recent report in Newsweek, more Americans younger than 50 are getting...

ONCY : 0.6901 (-6.74%)
GALT : 2.42 (-26.44%)
ONC.TO : 0.96 (-1.03%)
CGON : 25.55 (-2.78%)
CATX : 3.46 (+0.29%)
PRPH : 0.3360 (-8.30%)
Cancer Rates Are Surging in Young Adults -- Here's Where the Smart Money Is Going

/CNW/ -- USA News Group News Commentary – According to a recent report in Newsweek, more Americans younger than 50 are getting cancer. In fact, the report...

ONCY : 0.6901 (-6.74%)
GALT : 2.42 (-26.44%)
ONC.TO : 0.96 (-1.03%)
CGON : 25.55 (-2.78%)
CATX : 3.46 (+0.29%)
PRPH : 0.3360 (-8.30%)
CG Oncology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

CGON : 25.55 (-2.78%)
CG Oncology to Participate in the 2025 RBC Capital Markets Global Healthcare Conference

CGON : 25.55 (-2.78%)
Company News for May 14, 2025

Shares of Under Armour, Inc. (UAA) gained 1% after the company reported fourth-quarter fiscal 2025 loss of $0.08 per share, narrower than the Zacks Consensus Estimate of a loss of $0.09 per share. Landstar...

UAA : 7.03 (+13.94%)
LSTR : 136.81 (-0.24%)
SLAB : 141.30 (+0.20%)
CGON : 25.55 (-2.78%)
CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates

CGON : 25.55 (-2.78%)
SUO-CTC and CG Oncology Announce the 2025 Award Recipients for the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award

CGON : 25.55 (-2.78%)
Stocks Settle Mixed Awaiting Trade News and Big Tech Earnings

The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.28%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.03%. June E-mini S&P...

AMAT : 169.46 (-1.96%)
KHC : 25.80 (+0.47%)
$IUXX : 21,626.39 (-0.43%)
COIN : 308.38 (+4.43%)
ASML : 756.53 (-0.67%)
ZNU25 : 110-315s (+0.17%)
ESU25 : 6,018.00s (-0.27%)
QCOM : 151.32 (-1.50%)
KDP : 33.58 (+1.11%)
SJM : 96.93 (+1.01%)
$DOWI : 42,206.82 (+0.08%)
ONON : 52.67 (+1.54%)
Stocks Mixed on Trade News and Chip Stock Weakness

The S&P 500 Index ($SPX ) (SPY ) today is up +0.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.35%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.29%. June E-mini S&P futures (ESM25...

AMAT : 169.46 (-1.96%)
KHC : 25.80 (+0.47%)
$IUXX : 21,626.39 (-0.43%)
ASML : 756.53 (-0.67%)
ZNU25 : 110-315s (+0.17%)
ESU25 : 6,018.00s (-0.27%)
SJM : 96.93 (+1.01%)
AMD : 128.24 (+1.14%)
LLY : 762.73 (-2.84%)
$DOWI : 42,206.82 (+0.08%)
ONON : 52.67 (+1.54%)
CGON : 25.55 (-2.78%)
Stocks Climb on Hopes of US Trade Deals

The S&P 500 Index ($SPX ) (SPY ) today is up +0.44%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.71%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.25%. June E-mini S&P futures (ESM25...

AMAT : 169.46 (-1.96%)
AVGO : 249.99 (-0.51%)
$IUXX : 21,626.39 (-0.43%)
ASML : 756.53 (-0.67%)
DPZ : 447.28 (+0.11%)
ZNU25 : 110-315s (+0.17%)
ESU25 : 6,018.00s (-0.27%)
LYB : 58.34 (-0.51%)
AMD : 128.24 (+1.14%)
LLY : 762.73 (-2.84%)
$DOWI : 42,206.82 (+0.08%)
ONON : 52.67 (+1.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. CG Oncology is based in IRVINE, Calif.

See More

Key Turning Points

3rd Resistance Point 27.23
2nd Resistance Point 26.84
1st Resistance Point 26.20
Last Price 25.55
1st Support Level 25.17
2nd Support Level 24.78
3rd Support Level 24.14

See More

52-Week High 40.47
Fibonacci 61.8% 30.66
Fibonacci 50% 27.64
Last Price 25.55
Fibonacci 38.2% 24.61
52-Week Low 14.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
OSZAR »